Health Care & Life Sciences » Pharmaceuticals | Genomma Lab Internacional S.A.B.

Genomma Lab Internacional S.A.B. de C.V. | Cash Flow

Fiscal year is January-December. All values MXN Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,606
2,118
1,455
1,516
1,406
1,109
Depreciation, Depletion & Amortization
64
98
118
84
70
81
Other Funds
10
-
11
-
124
260
Funds from Operations
2,387
1,858
719
529
1,913
1,320
Changes in Working Capital
794
1,151
698
822
923
280
Net Operating Cash Flow
1,593
707
21
1,351
990
1,040
Capital Expenditures
2,732
904
128
113
311
Sale of Fixed Assets & Businesses
10
25
1,929
225
63
Net Investing Cash Flow
2,722
2,736
1,723
107
248
Issuance/Reduction of Debt, Net
2,038
1,473
719
350
1,136
Net Financing Cash Flow
2,045
1,460
1,233
1,427
1,264
Net Change in Cash
850
585
544
120
753
Free Cash Flow
1,552
587
77
1,239
727
Deferred Taxes & Investment Tax Credit
-
-
-
-
-
131
Net Assets from Acquisitions
-
1,857
18
-
-
Other Sources
-
-
-
40
-
Change in Capital Stock
3
12
525
1,077
4
Exchange Rate Effect
66
17
75
90
231
Other Uses
-
-
61
45
-

About Genomma Lab Internacional

View Profile
Address
Antonio Dovalí Jaime, 70, Piso 2
Mexico City Distrito Federal 01210
Mexico
Employees -
Website http://www.genommalab.com
Updated 07/08/2019
Genomma Lab Internacional SAB de CV engages in the development, manufacturing and marketing of pharmaceutical, beauty and personal care products. The company was founded on October 30, 1996 and is headquartered in México City, Mexico. .

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.